Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy

E Otten, RHLD Deprez, MM Weiss, M van Slegtenhorst, Marieke Joosten, JJ van der Smagt, N (Nicolaas) de Jonge, WS Kerstjens-Frederikse, MTR Roofthooft, Aggie Balk, Mijke Lambregtse - van den Berg, JS Ruiter, JP van Tintelen

Research output: Contribution to journalArticleAcademic

9 Citations (Scopus)

Abstract

Background. About 30% of dilated cardiomyopathy (DCM) cases are familial. Mutations are mostly found in the genes encoding lanain A/C, beta-myosin heavy chain and the sarcomeric protein cardiac troponin-T (TNNT2). Mutations in TNNT2 are reported in approximately 3% of DCM patients. The overall phenotype caused by TNNT2 mutations is thought to be a fully penetrant, severe disease. This also seems to be true for a recurrent deletion in the TNNT2 gene; p.K217del (also known as p.K210del). Methods. We compared the phenotype of all Dutch patients identified as carrying the TNNT2 p.K217de1 mutation with those described in the literature. All index patients underwent cardiological evaluation. Family screening was done in all described families. Results. Six DCM patients carrying the TNNT2 p.K217de1 mutation were identified from four Dutch families. Mean age of disease manifestation was 33 years. Heart transplantation was required in three of them at ages 12, 18 and 19 years. These outcomes are comparable with those described in the literature. Conclusion. Carriers of the TNNT2 p.K217de1 mutation in our Dutch families, as well as in families described in the literature before, generally show a severe, early-onset form of DCM. (Neth Heart J 2010;18:478-85.)
Original languageUndefined/Unknown
Pages (from-to)478-485
Number of pages8
JournalCardiologie (Hoogland)
Volume18
Issue number10
Publication statusPublished - 2010

Cite this